These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2693167)

  • 21. Complete long-term recovery of beta-cell function in autoimmune type 1 diabetes after insulin treatment.
    Karges B; Durinovic-Belló I; Heinze E; Boehm BO; Debatin KM; Karges W
    Diabetes Care; 2004 May; 27(5):1207-8. PubMed ID: 15111548
    [No Abstract]   [Full Text] [Related]  

  • 22. Partial preservation of pancreatic beta-cell function in children with diabetes.
    Elliott RB; Crossley JR; Berryman CC; James AG
    Lancet; 1981 Jul; 2(8236):1-4. PubMed ID: 6113394
    [No Abstract]   [Full Text] [Related]  

  • 23. Plasma C-peptide levels and clinical remissions in recent-onset type I diabetic patients treated with cyclosporin A and insulin.
    Assan R; Feutren G; Sirmai J; Laborie C; Boitard C; Vexiau P; Du Rostu H; Rodier M; Figoni M; Vague P
    Diabetes; 1990 Jul; 39(7):768-74. PubMed ID: 2191883
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of cyclosporine immunosuppression in insulin-dependent diabetes mellitus of recent onset.
    Stiller CR; Dupré J; Gent M; Jenner MR; Keown PA; Laupacis A; Martell R; Rodger NW; von Graffenried B; Wolfe BM
    Science; 1984 Mar; 223(4643):1362-7. PubMed ID: 6367043
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of i.v. tolbutamide on alpha- and beta-cell secretion in type I diabetes].
    Verga S; Donatelli M; Cerasola G; Sinagra D; Inglese CG; Terrizzi C
    Minerva Endocrinol; 1984; 9(3):339-42. PubMed ID: 6398400
    [No Abstract]   [Full Text] [Related]  

  • 26. Cyclosporin in diabetes.
    Koivisto VA; Pelkonen R
    Lancet; 1985 Feb; 1(8425):401. PubMed ID: 2857455
    [No Abstract]   [Full Text] [Related]  

  • 27. Beta-cell function in relation to islet cell antibodies during the first 3 yr after clinical diagnosis of diabetes in type II diabetic patients.
    Gottsäter A; Landin-Olsson M; Fernlund P; Lernmark A; Sundkvist G
    Diabetes Care; 1993 Jun; 16(6):902-10. PubMed ID: 8325204
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sensitivity and reproducibility of urinary C-peptide as estimate of islet B-cell function in insulin-treated diabetes.
    Gjessing HJ; Matzen LE; Faber OK; Frøland A
    Diabet Med; 1989; 6(4):329-33. PubMed ID: 2524338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-dose intravenous insulin infusion versus intensive insulin treatment in newly diagnosed IDDM.
    Schnell O; Eisfelder B; Standl E; Ziegler AG
    Diabetes; 1997 Oct; 46(10):1607-11. PubMed ID: 9313757
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ketoacidosis at diagnosis is predictive of lower residual beta-cell function and poor metabolic control in type 1 diabetes.
    Fernandez Castañer M; Montaña E; Camps I; Biarnes J; Merino JF; Escriba JM; Nacher V; Rosel P; Soler J
    Diabetes Metab; 1996 Oct; 22(5):349-55. PubMed ID: 8896997
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Remission in IDDM: prospective study of basal C-peptide and insulin dose in 268 consecutive patients.
    Agner T; Damm P; Binder C
    Diabetes Care; 1987; 10(2):164-9. PubMed ID: 3556104
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stability of disease-associated antibody titers in pregnant women with type 1 diabetes with or without residual beta-cell function.
    Novak EJ; Ortqvist E; Nord E; Edwall L; Hampe CS; Bekris L; Persson BE; Lernmark A
    Diabetes Care; 2000 Jul; 23(7):1019-21. PubMed ID: 10895858
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of immunosuppression with cyclosporine on beta cell function and clinical remission in very early overt type I diabetes.
    Dupre J; Stiller CR
    Adv Exp Med Biol; 1988; 246():347-55. PubMed ID: 3074665
    [No Abstract]   [Full Text] [Related]  

  • 34. Lack of effect of intermittently administered sodium fusidate in patients with newly diagnosed type 1 diabetes mellitus: the FUSIDM trial.
    Conget I; Aguilera E; Pellitero S; Näf S; Bendtzen K; Casamitjana R; Gomis R; Nicoletti F
    Diabetologia; 2005 Aug; 48(8):1464-8. PubMed ID: 15995847
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term results of early cyclosporin therapy in juvenile IDDM.
    De Filippo G; Carel JC; Boitard C; Bougnères PF
    Diabetes; 1996 Jan; 45(1):101-4. PubMed ID: 8522052
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diazoxide treatment at onset preserves residual insulin secretion in adults with autoimmune diabetes.
    Björk E; Berne C; Kämpe O; Wibell L; Oskarsson P; Karlsson FA
    Diabetes; 1996 Oct; 45(10):1427-30. PubMed ID: 8826981
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Residual B-cell function in type 1 (insulin-dependent) diabetes mellitus: its relation to clinical and metabolic features.
    Bonora E; Coscelli C; Butturini U
    Acta Diabetol Lat; 1984; 21(4):375-83. PubMed ID: 6397028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of nicotinamide treatment on the residual insulin secretion in type 1 (insulin-dependent) diabetic patients.
    Vague P; Picq R; Bernal M; Lassmann-Vague V; Vialettes B
    Diabetologia; 1989 May; 32(5):316-21. PubMed ID: 2526769
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The variable but inevitable loss of beta cells in overt type 1 diabetes.
    Rosenbloom AL
    Pediatr Diabetes; 2003 Mar; 4(1):1-3. PubMed ID: 14655516
    [No Abstract]   [Full Text] [Related]  

  • 40. Ten years' clinical experience of fetal islet transplantation.
    Farkas G; Szabó M; Vörös P
    Transplant Proc; 1992 Dec; 24(6):2954-5. PubMed ID: 1466012
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.